Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,914 papers from all fields of science
Search
Sign In
Create Free Account
ceftolozane / tazobactam
Known as:
CEFTOLOZANE/TAZOBACTAM
, Ceftolozane+Tazobactam
, ceftolozane - tazobactam
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Broader (4)
Anti-Infective Agents, Urinary
Cephalosporins
Penicillanic Acid
beta-Lactamase Inhibitors
Narrower (1)
Zerbaxa
analogs & derivatives
ceftolozane
tazobactam
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Measurement of ceftolozane and tazobactam concentrations in plasma by UHPLC-MS/MS. Clinical application in the management of difficult-to-treat osteoarticular infections.
R. Rigo-Bonnin
,
Joan Gómez-Junyent
,
+4 authors
O. Murillo
Clinica chimica acta; international journal of…
2019
Corpus ID: 53228951
2018
2018
Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy
M. Rawlins
,
Vesa Cheng
,
+6 authors
J. Roberts
Chemotherapy
2018
Corpus ID: 52958131
Background: Prolonged intermittent renal replacement therapy (PIRRT) eliminates many drugs, and without dosing data, for new…
Expand
2018
2018
Ceftolozane-tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a patient receiving intermittent hemodialysis.
Mohammed Alessa
,
Thamer A. Almangour
,
Abdulaziz Alhossan
,
Musaed Alkholief
,
M. Alhokail
,
Deanne E Tabb
American Journal of Health-System Pharmacy
2018
Corpus ID: 24463788
PURPOSE The safety and effectiveness of ceftolozane-tazobactam for the treatment of multidrug-resistant (MDR) Pseudomonas…
Expand
2018
2018
Failure of ceftolozane‐tazobactam salvage therapy in complicated pneumonia with lung abscess
P. Lewis
,
David B. Cluck
,
Jennifer L. Tharp
,
Matthew A Krolikowski
,
Paras D. Patel
Clinical Case Reports
2018
Corpus ID: 49656219
Treatment of Pseudomonas aeruginosa remains challenging, despite the availability ceftolozane‐tazobactam. We report a treatment…
Expand
2017
2017
Use of ceftolozane-tazobactam in a cystic fibrosis patient with multidrug-resistant pseudomonas infection and renal insufficiency
Katie Stokem
,
J. Zuckerman
,
D. Nicolau
,
Minkey Wungwattana
,
E. Sears
Respiratory Medicine Case Reports
2017
Corpus ID: 9578561
2017
2017
Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam
A. Hernández-Tejedor
,
Carmen Débora Merino-Vega
,
+7 authors
A. Algora-Weber
Infection
2017
Corpus ID: 27907908
IntroductionCeftolozane/tazobactam is a novel antibiotic approved for the treatment of complicated intra-abdominal and…
Expand
2017
2017
Effects of Clinically Meaningful Concentrations of Antipseudomonal β-Lactams on Time to Detection and Organism Growth in Blood Culture Bottles
M. Grupper
,
D. Nicolau
,
J. Aslanzadeh
,
Linda K Tanner
,
J. Kuti
Journal of Clinical Microbiology
2017
Corpus ID: 22872775
ABSTRACT The effectiveness of antimicrobial binding resins present in blood culture (BC) bottles in removing meropenem…
Expand
Review
2017
Review
2017
Are there any reasons to change our behavior in necrotizing fasciitis with the advent of new antibiotics?
F. Menichetti
,
S. Giuliano
,
Simona Fortunato
Current Opinion in Infectious Diseases
2017
Corpus ID: 1895084
Purpose of review The treatment of necrotizing fasciitis requires a multifaceted approach, consisting of surgical source control…
Expand
Review
2016
Review
2016
New Approaches to Antibiotic Use and Review of Recently Approved Antimicrobial Agents.
A. Hahn
,
R. Jain
,
D. Spach
The Medical clinics of North America
2016
Corpus ID: 9194446
Review
2015
Review
2015
Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections
Marion J. Skalweit
Drug Design, Development and Therapy
2015
Corpus ID: 16081831
Drug-resistant pathogens have gained a foothold especially in the most vulnerable patient populations, hospitalized and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE